Form 4: Alkermes Director Richard Gaynor Reports Vesting of Restricted Stock Units and Related Share Transactions

Alkermes plc Director Richard Gaynor has reported the vesting of 8,013 restricted stock units and the subsequent disposition of 1,924 shares for tax withholding purposes, increasing his direct beneficial ownership to 31,084 ordinary shares.

Summary

• Richard Gaynor, a Director of Alkermes plc (ALKS), reported changes in his beneficial ownership of the company's ordinary shares.
• On May 31, 2025, Mr. Gaynor acquired 8,013 ordinary shares through the vesting of restricted stock units (RSUs).
• Each restricted stock unit represents a contingent right to receive one ordinary share, and this specific award was fully vested.
• Concurrently, Mr. Gaynor disposed of 1,924 ordinary shares at a price of $30.61 per share, likely to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, Mr. Gaynor's direct beneficial ownership of Alkermes ordinary shares stands at 31,084.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there's a sale of shares, it's for tax purposes related to a vesting event, which is a positive for the director. The net effect is an increase in direct beneficial ownership, indicating continued commitment.

Positives

• The vesting of 8,013 restricted stock units indicates a successful milestone for the director's compensation plan.
• Despite the sale for tax purposes, the net effect is an increase in the director's direct beneficial ownership of ordinary shares, demonstrating continued alignment with shareholder interests.

Negatives

• A portion of the newly acquired shares (1,924 shares) was immediately sold, which, while common for tax purposes, represents a reduction in the total shares acquired from the vesting event.

Future Outlook

This Form 4 filing reports past transactions and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

Form 4 filings are routine disclosures in the U.S. financial markets, providing transparency into insider trading activities. The vesting of restricted stock units and subsequent 'sell-to-cover' transactions for tax purposes are common occurrences in executive compensation plans across all industries, including pharmaceuticals and biotechnology.

Stakeholder Impact

• Shareholders: Provides transparency into a director's equity holdings and compensation, showing continued alignment of interests through increased direct ownership.
• Employees: Reflects standard equity compensation practices for senior management.

Key Dates

Keywords

Alkermes, ALKS, Form 4, Insider Transaction, Restricted Stock Unit, RSU, Director Ownership, Share Vesting, Equity Compensation